الجمعة، 21 ديسمبر 2012

Sedative (albnzodayazabin) may increase the risk of lung inflammation diseases

Dr. Ibrahim Ibn Hasan al-Khudayr

The study said that the sedative (albnzodayazabin) are associated with increased risk of lung inflammation, disease and possibly leading to the death of patients with diseases of lung infections. According to a report published in the British journal Thorax, electronic, British researchers examined the cases of 29571 as officer and 4964 for persons suffering from pulmonary infections acquired, such information has been collected from primary health care patients files, from the British health services improvement network, to examine the link between albnzodayazabin and sedative disease pneumonia. Researchers found that diazepam (valium) wallorazibam (ativan) and altimazibam (hypnotic medication) but not a alklorodiziboxid associated with increased incidence of severe lung infections. As a pharmaceutical group, albnzodayazabin is linked to increased approximately 30 days and long-term death patients diagnosed with inflammatory lung disease. As each drug separately solo, diazepam (valium) and allaura zibam (ativan) and altimazibam (hypnotic medication) affect the long-term death patients with lung infections.

ليست هناك تعليقات:

إرسال تعليق